PGEN

Precigen, Inc.

Phase 2 AI-extracted

PAPZIMEOS

Recurrent Respiratory Papillomatosis (RRP)

Date

TBD

Phase 2 readout · Date TBD estimated

What's at stake Phase 2 trial results for PAPZIMEOS in Recurrent Respiratory Papillomatosis (RRP) are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 17h ago

“PRGN-2009 Phase 2 clinical trial in combination with pembrolizumab in recurrent/metastatic cervical cancer is ongoing.”

Add to calendar Post on X Reddit

Provenance